Fundraising Fox

CYduct Diagnostics

OTC: CYDX

Westport, US · Nevada corporation

CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.

Founders & leadership

GL
Gatto L DomNamed on SEC filing
DG
Dom GattoFounder & CEO
CM
Claus MadsenNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.1M disclosed across 2 rounds · 2021–2026

$2MraisedJul 2026 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gatto L DomExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
First sale
Jun 2026
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100KraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dom GattoExecutive Officer, Director
  • Claus MadsenExecutive Officer
Offering amount
$2M
Amount sold
$100K
Minimum investment
$25K
Proceeds to insiders
$275K
First sale
Nov 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does CYduct Diagnostics do?
CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.
How much funding has CYduct Diagnostics raised?
CYduct Diagnostics has disclosed $2.1M raised across 2 rounds.
Where is CYduct Diagnostics headquartered?
CYduct Diagnostics is headquartered in Westport, US.